---
document_datetime: 2023-09-21 18:03:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aldurazyme-epar-all-authorised-presentations_en.pdf
document_name: aldurazyme-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8885353
conversion_datetime: 2025-12-19 21:09:51.024088
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical Form                   | Route of        | Packaging    | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|---------------------------------------|-----------------|--------------|---------------------------|----------------|
| EU/1/03/253/001 | Aldurazyme      | 100 U/ml   | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 5 ml (100 U/ml)           | 1 vial         |
| EU/1/03/253/002 | Aldurazyme      | 100 U/ml   | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 5 ml (100 U/ml)           | 10 vials       |
| EU/1/03/253/003 | Aldurazyme      | 100 U/ml   | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 5 ml (100 U/ml)           | 25 vials       |